It takes two to simulate clinical trials.

As your partner, we’ll pull out all the stops to deliver the results you need. How exactly do we do that? We’re glad you asked.

We perform innovative analyses that result in new findings and shed light on difficult challenges.

Then we synthesize these findings with existing knowledge to place results into an appropriate context for decision-making.

Finally, we overcome time constraints and deliver results to meet aggressive developmental milestones.

But we don’t stop there – not even close. We also hold a firm belief that our relationship with you is just as important as the analytical work. So don’t expect us to disappear with your data and return with “the answer.” In our experience, successful projects almost always involve a high level of collaboration. Working together allows us to complete analyses as quickly as possible, integrate findings into the submission package story, and ensures both you and the regulators understand what we did, why we did it, and what the implications of our work may be.

Harness the power of pharmacometrics.

Raise your hand if you wish there was a way to make drug development more efficient. Guess what? There is. It’s called model-based drug development, and it involves using quantitative analysis to better design protocols, determine dosage levels, and figure out other neat stuff that lead to successful regulatory filings. Once you see how incredible (and cost-effective) pharmacometrics can be, you’ll be hooked.